Harvard Bioscience Income Statement (2010-2025) | HBIO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	26.99M	29.20M	29.66M	33.05M	28.78M	29.21M	26.92M	28.43M	29.98M	28.76M	25.36M	28.15M	24.51M	23.10M	21.97M	24.56M	21.77M	20.45M	20.59M	23.73M
Cost of Revenue (Quarter)	5.39M	12.84M	6.18M	33.95M	12.60M	6.59M	14.75M	12.59M	5.98M	6.18M	10.64M	28.29M	9.74M	9.88M	5.52M	37.98M	9.59M	8.92M	8.57M	5.09M
Gross Profit (Quarter)	15.43M	16.35M	16.31M	19.56M	16.18M	16.64M	12.17M	15.83M	18.35M	16.67M	14.73M	16.32M	14.77M	13.22M	12.77M	14.01M	12.18M	11.53M	12.02M	14.17M
Operating items
Amortization - Intangibles (Quarter)	1.50M	1.47M	1.50M	1.44M	1.47M	1.45M	1.60M	1.63M	1.39M	1.39M	1.36M	1.39M	1.33M	1.33M	1.33M	1.26M	1.16M	1.16M	0.85M	0.85M
Research & Development (Quarter)	2.49M	2.70M	2.66M	2.95M	3.22M	3.50M	2.76M	2.85M	2.90M	2.96M	2.76M	3.15M	2.88M	2.63M	2.57M	2.33M	2.32M	2.19M	2.13M	2.18M
Selling, General & Administrative (Quarter)	6.33M	6.40M	5.46M	6.12M	6.33M	5.98M	6.32M	5.86M	6.33M	5.35M	5.81M	5.26M	5.96M	5.69M	5.04M	4.80M	5.18M	4.26M	4.18M	4.12M
Restructuring Costs (Quarter)				0.30M	5.19M	-4.90M	-0.54M							0.40M	0.18M		0.09M	0.03M	0.05M
Other Operating Expenses (Quarter)	6.85M	7.20M	7.64M	8.49M	8.15M	8.06M	7.39M	7.58M	7.37M	7.57M	7.09M	7.63M	8.20M	6.58M	6.85M	6.87M	54.25M	5.87M	5.47M	6.16M
Operating Expenses (Quarter)	15.67M	16.30M	15.76M	17.86M	22.89M	12.64M	15.93M	16.29M	16.60M	15.88M	15.66M	16.04M	17.05M	15.29M	14.64M	14.00M	61.85M	12.35M	11.82M	12.46M
Operating Income (Quarter)	-0.24M	0.06M	0.55M	1.70M	-6.71M	4.00M	-3.76M	4.55M	1.75M	0.80M	-0.93M	0.28M	-2.28M	-2.07M	-1.87M	3.77M	-49.67M	-0.82M	0.20M	38.33M
EBIT (Quarter)	-0.24M	0.06M	0.55M	1.70M	-6.71M	4.00M	-3.76M	4.55M	1.75M	0.80M	-0.93M	0.28M	-2.28M	-2.07M	-1.87M	3.77M	-49.67M	-0.82M	0.20M	38.33M
Non-operating items
Interest & Investment Income (Quarter)	-0.41M	-0.38M	-0.37M	-0.38M	-0.38M	-0.52M	-0.75M	-0.90M	-0.97M	-0.94M	-0.88M	-0.79M	-0.75M	-0.75M	-0.86M	-1.18M	-0.80M	-0.79M	-0.97M	-2.36M
Other Non Operating Income (Quarter)	-0.03M	-0.31M	-0.13M	-0.19M	0.08M	-0.06M	-0.18M	0.47M	0.43M	-0.37M	0.04M	-0.33M	-0.14M	-0.18M	-0.52M	0.52M	-0.32M	-0.64M	-0.36M	-1.32M
Non Operating Income (Quarter)	-0.45M	-0.31M	-0.50M	-0.19M	-0.31M	-0.06M	-0.93M	2.11M	-0.54M	-0.37M	0.37M	2.84M	-0.14M	-0.18M	-0.52M	0.58M	-1.13M	-1.44M	-0.36M	-7.47M
Net income details
EBT (Quarter)	-0.68M	-0.63M	0.04M	1.13M	-7.02M	3.42M	-4.69M	-0.89M	1.21M	-2.10M	-0.56M	-1.10M	-4.48M	-3.28M	-4.49M	0.59M	-50.79M	-2.25M	-1.13M	-3.20M
Tax Provisions (Quarter)	-0.01M	-0.22M	0.21M	0.54M	-0.10M	0.99M	-1.28M	0.77M	0.58M	-1.10M	0.68M	0.49M	0.20M	-0.40M	0.30M	0.26M	-0.45M	0.03M	0.10M	0.17M
Profit After Tax (Quarter)	-0.67M	-0.41M	-0.17M	0.96M	-6.88M	2.44M	-3.40M	-1.67M	0.62M	-0.98M	-1.24M	-1.82M	-4.69M	-2.93M	-4.80M	0.02M	-50.34M	-2.28M	-1.23M	-2.85M
Equity Income (Quarter)										-1.58M	1.21M	-0.26M	-1.31M	-0.28M
Income from Continuing Operations (Quarter)	-0.67M	-0.41M	-0.17M	0.59M	-6.92M	2.44M	-3.40M	-1.67M	0.62M	-1.00M	-1.24M	-1.59M	-4.68M	-2.88M	-4.79M	0.33M	-50.34M	-2.28M	-1.23M	-3.37M
Consolidated Net Income (Quarter)	-0.67M	-0.41M	-0.17M	0.59M	-6.92M	2.44M	-3.40M	-1.67M	0.62M	-1.00M	-1.24M	-1.59M	-4.68M	-2.88M	-4.79M	0.33M	-50.34M	-2.28M	-1.23M	-3.37M
Income towards Parent Company (Quarter)	-0.67M	-0.41M	-0.17M	0.59M	-6.92M	2.44M	-3.40M	-1.67M	0.62M	-1.00M	-1.24M	-1.59M	-4.68M	-2.88M	-4.79M	0.33M	-50.34M	-2.28M	-1.23M	-3.37M
Net Income towards Common Stockholders (Quarter)	-0.67M	-0.41M	-0.17M	0.59M	-6.92M	2.44M	-3.40M	-1.67M	0.62M	-0.98M	-1.24M	-1.59M	-4.68M	-2.88M	-4.79M	0.33M	-50.34M	-2.28M	-1.23M	-3.37M
Additional items
EPS (Basic) (Quarter)	-0.02	-0.01	-4.17	0.02	-0.17	0.06	-0.08	-0.04	0.01	-0.02	-0.03	-0.04	-0.11	-0.07	-0.11	0.01	-1.14	-0.05	-0.03	-0.06
EPS (Weighted Average and Diluted) (Quarter)		-0.01	0.00	0.01	-0.17	0.06		-0.04	0.01	-0.02		-0.04	-0.11	-0.07		0.01		-0.05		-0.08
Shares Outstanding (Weighted Average) (Quarter)	39.79M	40.15M	0.04M	40.34M	41.22M	41.26M	41.64M	41.41M	42.12M	42.20M	42.34M	42.42M	43.40M	43.49M	43.61M	43.54M	44.10M	44.20M	44.56M	44.39M
Shares Outstanding (Diluted Average) (Quarter)			40.75M	40.34M		42.56M		41.41M	42.78M	42.20M		42.42M	43.40M	43.44M		43.54M		44.20M		44.39M
EBITDA (Quarter)	-0.24M	0.06M	0.55M	1.70M	-6.71M	4.00M	-3.76M	4.55M	1.75M	0.80M	-0.93M	0.28M	-2.28M	-2.07M	-1.87M	3.77M	-49.67M	-0.82M	0.20M	38.33M
Interest Expenses (Quarter)
Tax Rate (Quarter)	2.19%	35.13%	477.78%	47.83%	1.42%	28.82%	27.40%	-86.77%	48.47%	52.43%	-120.46%	-44.15%	-4.46%	12.20%	-6.68%	44.41%	0.89%	-1.33%	-8.82%	-5.21%

Research Tools

Harvard Bioscience Income Statement (2010-2025) | HBIO

Create an account

Sign In

Reset Password